Clinical Trials Directory

Trials / Completed

CompletedNCT05525390

Extended Reality Behavioral Activation: An Intervention for Major Depressive Disorder

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
26 (actual)
Sponsor
Stanford University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The primary aims of this study are to assess the feasibility, acceptability, and tolerability of using an immersive extended reality (XR) headset to engage in behavioral activation (BA) for individuals diagnosed with major depressive disorder (MDD). The secondary aim of this study is to explore the efficacy of using XR to enhance BA therapy in a clinical MDD population.

Detailed description

This is a treatment development trial. Participants will be randomized to receive either XR-enhanced behavioral activation or traditional behavioral activation. All groups will follow a brief-BA protocol developed for primary care settings over a four-session, three-week treatment period.

Conditions

Interventions

TypeNameDescription
BEHAVIORALExtended Reality-Enhanced Behavioral ActivationParticipants will choose at least four "activities" to complete in Oculus extended reality over the course of the week. These activities are chosen from the Oculus and may include video 360, social interactions, gaming, etc.
BEHAVIORALTraditional Behavioral ActivationParticipants will choose at least four pleasurable and/or mastery activities to complete over the course of the week in real life.

Timeline

Start date
2022-12-19
Primary completion
2023-07-24
Completion
2023-07-24
First posted
2022-09-01
Last updated
2025-09-22

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05525390. Inclusion in this directory is not an endorsement.